Trade DENTSPLY SIRONA Inc. - XRAY CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.12 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026151% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003929% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
DENTSPLY SIRONA Inc ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Prev. Close* | 34.04 |
Open* | 34.1 |
1-Year Change* | 16.3% |
Day's Range* | 33.8 - 34.23 |
52 wk Range | 26.48-43.24 |
Average Volume (10 days) | 1.27M |
Average Volume (3 months) | 30.37M |
Market Cap | 7.66B |
P/E Ratio | -100.00K |
Shares Outstanding | 211.72M |
Revenue | 3.94B |
EPS | -4.77 |
Dividend (Yield %) | 1.54867 |
Beta | 0.98 |
Next Earnings Date | Nov 13, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Sep 27, 2023 | 34.04 | -0.27 | -0.79% | 34.31 | 34.79 | 33.69 |
Sep 26, 2023 | 34.51 | 0.77 | 2.28% | 33.74 | 34.70 | 33.54 |
Sep 25, 2023 | 34.10 | 0.39 | 1.16% | 33.71 | 34.13 | 33.62 |
Sep 22, 2023 | 33.79 | -0.19 | -0.56% | 33.98 | 34.17 | 33.55 |
Sep 21, 2023 | 34.09 | -0.41 | -1.19% | 34.50 | 34.85 | 33.98 |
Sep 20, 2023 | 35.12 | -0.06 | -0.17% | 35.18 | 35.78 | 35.04 |
Sep 19, 2023 | 35.22 | 0.23 | 0.66% | 34.99 | 35.58 | 34.99 |
Sep 18, 2023 | 35.47 | 0.19 | 0.54% | 35.28 | 35.59 | 34.92 |
Sep 15, 2023 | 35.49 | 0.21 | 0.60% | 35.28 | 36.04 | 34.84 |
Sep 14, 2023 | 35.52 | -0.15 | -0.42% | 35.67 | 36.27 | 35.30 |
Sep 13, 2023 | 35.71 | -0.75 | -2.06% | 36.46 | 36.50 | 35.68 |
Sep 12, 2023 | 36.60 | 0.53 | 1.47% | 36.07 | 36.79 | 35.99 |
Sep 11, 2023 | 36.52 | 0.58 | 1.61% | 35.94 | 36.74 | 35.81 |
Sep 8, 2023 | 35.93 | 0.04 | 0.11% | 35.89 | 36.20 | 35.83 |
Sep 7, 2023 | 36.09 | -0.52 | -1.42% | 36.61 | 36.70 | 36.02 |
Sep 6, 2023 | 36.64 | 0.21 | 0.58% | 36.43 | 36.84 | 36.15 |
Sep 5, 2023 | 36.62 | -0.50 | -1.35% | 37.12 | 37.22 | 36.52 |
Sep 1, 2023 | 37.43 | 0.21 | 0.56% | 37.22 | 37.45 | 37.11 |
Aug 31, 2023 | 37.05 | -0.22 | -0.59% | 37.27 | 37.63 | 37.01 |
Aug 30, 2023 | 37.27 | -0.24 | -0.64% | 37.51 | 37.75 | 37.11 |
DENTSPLY SIRONA Inc. Events
Time (UTC) | Country | Event |
---|---|---|
Monday, November 13, 2023 | ||
Time (UTC) 13:30 | Country US
| Event Q3 2023 DENTSPLY SIRONA Inc Earnings Release Q3 2023 DENTSPLY SIRONA Inc Earnings ReleaseForecast -Previous - |
Monday, February 26, 2024 | ||
Time (UTC) 13:30 | Country US
| Event Q4 2023 DENTSPLY SIRONA Inc Earnings Release Q4 2023 DENTSPLY SIRONA Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 3922 | 4231 | 3339 | 4022 | 3986.3 |
Revenue | 3922 | 4231 | 3339 | 4022 | 3986.3 |
Cost of Revenue, Total | 1795 | 1887 | 1639 | 1833 | 1918.5 |
Gross Profit | 2127 | 2344 | 1700 | 2189 | 2067.8 |
Total Operating Expense | 4862 | 3623 | 3342 | 3670 | 4944.4 |
Selling/General/Admin. Expenses, Total | 1589 | 1545 | 1300 | 1564 | 1558.6 |
Research & Development | 174 | 171 | 123 | 143 | 160.5 |
Unusual Expense (Income) | 1304 | 20 | 280 | 130 | 1306.8 |
Operating Income | -940 | 608 | -3 | 352 | -958.1 |
Interest Income (Expense), Net Non-Operating | -107 | -49 | -33 | 0 | -30.6 |
Other, Net | -8 | -14 | -14 | -14 | 30.3 |
Net Income Before Taxes | -1055 | 545 | -50 | 338 | -958.4 |
Net Income After Taxes | -950 | 411 | -73 | 256 | -1015 |
Minority Interest | 0 | 0 | 0 | 0 | -0.1 |
Equity In Affiliates | |||||
Net Income Before Extra. Items | -950 | 411 | -73 | 256 | -1015.1 |
Net Income | -950 | 411 | -73 | 256 | -1011 |
Income Available to Common Excl. Extra. Items | -950 | 411 | -73 | 256 | -1015.1 |
Income Available to Common Incl. Extra. Items | -950 | 411 | -73 | 256 | -1011 |
Diluted Net Income | -950 | 411 | -73 | 256 | -1011 |
Diluted Weighted Average Shares | 215.5 | 220.2 | 219.2 | 224.4 | 224.3 |
Diluted EPS Excluding Extraordinary Items | -4.40835 | 1.86649 | -0.33303 | 1.14082 | -4.52564 |
Dividends per Share - Common Stock Primary Issue | 0.5 | 0.43 | 0.4 | 0.375 | 0.35 |
Diluted Normalized EPS | -0.47517 | 1.93498 | 0.49726 | 1.5796 | -0.67258 |
Total Extraordinary Items | 4.1 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 1028 | 978 | 983 | 947 | 1023 |
Revenue | 1028 | 978 | 983 | 947 | 1023 |
Cost of Revenue, Total | 478 | 455 | 466 | 439 | 442 |
Gross Profit | 550 | 523 | 517 | 508 | 581 |
Total Operating Expense | 948 | 980 | 921 | 2165 | 904 |
Selling/General/Admin. Expenses, Total | 416 | 416 | 402 | 401 | 410 |
Research & Development | 49 | 46 | 43 | 41 | 45 |
Unusual Expense (Income) | 5 | 63 | 10 | 1284 | 7 |
Operating Income | 80 | -2 | 62 | -1218 | 119 |
Interest Income (Expense), Net Non-Operating | -32 | -23 | -53 | -21 | -25 |
Other, Net | -2 | -3 | -1 | -2 | -3 |
Net Income Before Taxes | 46 | -28 | 8 | -1241 | 91 |
Net Income After Taxes | 85 | -23 | -15 | -1077 | 73 |
Minority Interest | 1 | 4 | 0 | 0 | 0 |
Net Income Before Extra. Items | 86 | -19 | -15 | -1077 | 73 |
Net Income | 86 | -19 | -15 | -1077 | 73 |
Income Available to Common Excl. Extra. Items | 86 | -19 | -15 | -1077 | 73 |
Income Available to Common Incl. Extra. Items | 86 | -19 | -15 | -1077 | 73 |
Diluted Net Income | 86 | -19 | -15 | -1077 | 73 |
Diluted Weighted Average Shares | 213.1 | 214.5 | 215.2 | 214.9 | 215.3 |
Diluted EPS Excluding Extraordinary Items | 0.40357 | -0.08858 | -0.0697 | -5.01163 | 0.33906 |
Dividends per Share - Common Stock Primary Issue | 0.14 | 0.14 | 0.125 | 0.125 | 0.125 |
Diluted Normalized EPS | 0.41882 | 0.10233 | -0.0395 | -1.12797 | 0.36514 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 1893 | 1852 | 1798 | 1999.9 | 1888 |
Cash and Short Term Investments | 365 | 339 | 438 | 404.9 | 309.6 |
Cash & Equivalents | 365 | 339 | 438 | 404.9 | 309.6 |
Total Receivables, Net | 685 | 750 | 667 | 782 | 701.9 |
Accounts Receivable - Trade, Net | 632 | 750 | 667 | 782 | 701.9 |
Total Inventory | 627 | 515 | 476 | 561.7 | 598.9 |
Prepaid Expenses | 128 | 248 | 150 | 121.7 | 133 |
Other Current Assets, Total | 88 | 67 | 129.6 | 144.6 | |
Total Assets | 7643 | 9239 | 9350 | 8602.9 | 8687 |
Property/Plant/Equipment, Total - Net | 961 | 971 | 967 | 961.7 | 870.6 |
Goodwill, Net | 2688 | 3976 | 3986 | 3396.5 | 3431.3 |
Intangibles, Net | 1903 | 2319 | 2504 | 2176.3 | 2420.3 |
Long Term Investments | |||||
Other Long Term Assets, Total | 198 | 121 | 95 | 68.5 | 76.8 |
Total Current Liabilities | 1170 | 1261 | 1372 | 995.5 | 1013.3 |
Accounts Payable | 279 | 262 | 302 | 307.9 | 283.9 |
Accrued Expenses | 624 | 760 | 627 | 594.4 | 546.8 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 118 | 182 | 299 | 2.3 | 92.4 |
Other Current Liabilities, Total | 149 | 57 | 144 | 90.9 | 90.2 |
Total Liabilities | 3832 | 4243 | 4418 | 3510.4 | 3565.9 |
Total Long Term Debt | 1826 | 1913 | 1978 | 1433.1 | 1564.9 |
Long Term Debt | 1825 | 1913 | 1977 | 1431.8 | 1564.9 |
Deferred Income Tax | 287 | 391 | 381 | 479.6 | 552.8 |
Minority Interest | 1 | 1 | 3 | 2.4 | 11.9 |
Other Liabilities, Total | 548 | 677 | 684 | 599.8 | 423 |
Total Equity | 3811 | 4996 | 4932 | 5092.5 | 5121.1 |
Common Stock | 3 | 3 | 3 | 2.6 | 2.6 |
Additional Paid-In Capital | 6629 | 6606 | 6604 | 6586.7 | 6522.3 |
Retained Earnings (Accumulated Deficit) | 456 | 1514 | 1198 | 1404.2 | 1225.9 |
Treasury Stock - Common | -2649 | -2535 | -2409 | -2301.3 | -2151 |
Other Equity, Total | -628 | -592 | -464 | -599.7 | -478.7 |
Total Liabilities & Shareholders’ Equity | 7643 | 9239 | 9350 | 8602.9 | 8687 |
Total Common Shares Outstanding | 215.3 | 217.4 | 218.7 | 221.3 | 223 |
Property/Plant/Equipment, Total - Gross | 2273 | 2359 | 2194.3 | 2076.8 | |
Accumulated Depreciation, Total | -1312 | -1392 | -1232.6 | -1206.2 | |
Unrealized Gain (Loss) | 0 | ||||
Capital Lease Obligations | 1 | 1 | 1.3 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total Current Assets | 1943 | 1893 | 1939 | 1885 | 1897 |
Cash and Short Term Investments | 318 | 365 | 418 | 362 | 374 |
Cash & Equivalents | 318 | 365 | 418 | 362 | 374 |
Total Receivables, Net | 652 | 685 | 645 | 661 | 707 |
Accounts Receivable - Trade, Net | 652 | 632 | 645 | 661 | 707 |
Total Inventory | 659 | 627 | 592 | 581 | 553 |
Prepaid Expenses | 314 | 128 | 284 | 281 | 263 |
Total Assets | 7673 | 7643 | 7522 | 8948 | 9172 |
Property/Plant/Equipment, Total - Net | 961 | 961 | 915 | 949 | 975 |
Goodwill, Net | 2701 | 2688 | 2584 | 3858 | 3944 |
Intangibles, Net | 1862 | 1903 | 1875 | 2100 | 2228 |
Other Long Term Assets, Total | 206 | 198 | 209 | 156 | 128 |
Total Current Liabilities | 1374 | 1170 | 1296 | 1241 | 1372 |
Accounts Payable | 267 | 279 | 271 | 289 | 277 |
Accrued Expenses | 655 | 727 | 711 | 688 | 694 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 316 | 118 | 246 | 220 | 347 |
Other Current Liabilities, Total | 136 | 46 | 68 | 44 | 54 |
Total Liabilities | 4032 | 3832 | 3909 | 4111 | 4309 |
Total Long Term Debt | 1842 | 1826 | 1737 | 1807 | 1872 |
Long Term Debt | 1842 | 1825 | 1737 | 1807 | 1872 |
Deferred Income Tax | 271 | 287 | 246 | 409 | 389 |
Minority Interest | -3 | 1 | 1 | 1 | 1 |
Other Liabilities, Total | 548 | 548 | 629 | 653 | 675 |
Total Equity | 3641 | 3811 | 3613 | 4837 | 4863 |
Common Stock | 3 | 3 | 3 | 3 | 3 |
Additional Paid-In Capital | 6604 | 6629 | 6619 | 6617 | 6573 |
Retained Earnings (Accumulated Deficit) | 407 | 456 | 498 | 1602 | 1556 |
Treasury Stock - Common | -2759 | -2649 | -2663 | -2666 | -2640 |
Other Equity, Total | -614 | -628 | -844 | -719 | -629 |
Total Liabilities & Shareholders’ Equity | 7673 | 7643 | 7522 | 8948 | 9172 |
Total Common Shares Outstanding | 212.5 | 215.3 | 214.9 | 214.8 | 215.5 |
Other Current Assets, Total | 88 | ||||
Capital Lease Obligations | 1 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -950 | 411 | -73 | 256 | -1010.9 |
Cash From Operating Activities | 517 | 657 | 649 | 639 | 499.8 |
Cash From Operating Activities | 119 | 124 | 142 | 133 | 132.9 |
Amortization | 209 | 222 | 192 | 190 | 197.9 |
Deferred Taxes | -228 | -25 | -62 | -40 | -62 |
Non-Cash Items | 1445 | 68 | 250 | 116 | 1275.1 |
Cash Taxes Paid | 122 | 148 | 82 | 112 | 104.7 |
Cash Interest Paid | 70 | 64 | 45 | 30 | 35.1 |
Changes in Working Capital | -78 | -143 | 200 | -16 | -33.2 |
Cash From Investing Activities | -138 | -358 | -1106 | -69 | -253.3 |
Capital Expenditures | -149 | -142 | -87 | -123 | -188 |
Other Investing Cash Flow Items, Total | 11 | -216 | -1019 | 54 | -65.3 |
Cash From Financing Activities | -329 | -379 | 476 | -472 | -249.8 |
Financing Cash Flow Items | -21 | -36 | -56 | -40 | 0 |
Total Cash Dividends Paid | -104 | -92 | -88 | -81 | -78.6 |
Issuance (Retirement) of Stock, Net | -144 | -149 | -129 | -151 | -222.3 |
Issuance (Retirement) of Debt, Net | -60 | -102 | 749 | -200 | 51.1 |
Foreign Exchange Effects | -24 | -19 | 14 | -3 | -7.7 |
Net Change in Cash | 26 | -99 | 33 | 95 | -11 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -23 | -950 | -935 | 142 | 69 |
Cash From Operating Activities | -21 | 517 | 375 | 266 | 93 |
Cash From Operating Activities | 31 | 119 | 90 | 59 | 29 |
Amortization | 53 | 209 | 159 | 108 | 55 |
Deferred Taxes | -21 | -228 | -220 | -13 | -14 |
Non-Cash Items | 78 | 1445 | 1366 | 62 | 13 |
Changes in Working Capital | -139 | -78 | -85 | -92 | -59 |
Cash From Investing Activities | -37 | -138 | -109 | -83 | -43 |
Capital Expenditures | -39 | -149 | -117 | -85 | -44 |
Other Investing Cash Flow Items, Total | 2 | 11 | 8 | 2 | 1 |
Cash From Financing Activities | 17 | -329 | -168 | -162 | -10 |
Financing Cash Flow Items | -4 | -21 | -15 | -8 | -7 |
Total Cash Dividends Paid | -27 | -104 | -78 | -51 | -24 |
Issuance (Retirement) of Stock, Net | -150 | -144 | -144 | -144 | -145 |
Issuance (Retirement) of Debt, Net | 198 | -60 | 69 | 41 | 166 |
Foreign Exchange Effects | -6 | -24 | -19 | 2 | -5 |
Net Change in Cash | -47 | 26 | 79 | 23 | 35 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 11.7083 | 24788312 | -421577 | 2023-06-30 | LOW |
Artisan Partners Limited Partnership | Investment Advisor | 6.3644 | 13474353 | -257843 | 2023-06-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.2517 | 11118606 | 98024 | 2023-06-30 | LOW |
First Eagle Investment Management, L.L.C. | Investment Advisor/Hedge Fund | 4.5986 | 9735915 | -18910 | 2023-06-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.485 | 9495526 | 254642 | 2023-06-30 | LOW |
Nuance Investments, LLC | Investment Advisor | 4.2582 | 9015249 | -1946666 | 2023-06-30 | MED |
Janus Henderson Investors | Investment Advisor/Hedge Fund | 3.6482 | 7723734 | 18100 | 2023-06-30 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 3.2144 | 6805349 | 144391 | 2023-06-30 | LOW |
T. Rowe Price Associates, Inc. | Investment Advisor | 3.1773 | 6726894 | -781200 | 2023-06-30 | LOW |
Cooke & Bieler, L.P. | Investment Advisor | 2.4995 | 5291758 | -431880 | 2023-06-30 | LOW |
T. Rowe Price Investment Management, Inc. | Investment Advisor | 2.3855 | 5050537 | -25241 | 2023-06-30 | LOW |
Morgan Stanley & Co. LLC | Research Firm | 2.3196 | 4910911 | -994527 | 2023-06-30 | MED |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 2.2722 | 4810653 | 60742 | 2023-06-30 | LOW |
Generation Investment Management LLP | Investment Advisor/Hedge Fund | 2.1867 | 4629554 | -74081 | 2023-06-30 | LOW |
Champlain Investment Partners, LLC | Investment Advisor | 1.8306 | 3875642 | 9025 | 2023-06-30 | LOW |
Mackenzie Financial Corporation | Investment Advisor/Hedge Fund | 1.2368 | 2618474 | -1715210 | 2023-06-30 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 1.1916 | 2522902 | -5846 | 2023-06-30 | LOW |
Invesco Capital Management LLC | Investment Advisor | 1.1693 | 2475650 | 196715 | 2023-06-30 | LOW |
Invesco Advisers, Inc. | Investment Advisor | 1.0633 | 2251257 | -546826 | 2023-06-30 | LOW |
American Century Investment Management, Inc. | Investment Advisor/Hedge Fund | 1.0396 | 2201024 | -625074 | 2023-06-30 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Dentsply Company profile
About DENTSPLY SIRONA Inc
DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. The Company develops, manufactures and markets solutions, including dental equipment and dental consumable products. The Company’s segments include Technologies & Equipment (T&E) and Consumables. The T&E segment is engaged in designing, manufacturing, sales and distribution of its Dental Technology and Equipment Products and Healthcare Consumable Products. Its products include dental implants, computer-aided design/computer-aided manufacturing systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as consumable medical device products. The Consumables segment is engaged in designing, manufacturing, sales and distribution of the Company's Dental Consumable Products, which include preventive, restorative, endodontic and dental laboratory products. It also offers treatment planning and a clear aligner solution delivered directly to a consumer's home.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, DENTSPLY SIRONA Inc revenues increased 27% to $4.25B. Net income totaled $421M vs. loss of $83M. Revenues reflect Technologies & Equipment segment increase of 29% to $2.52B, Consumables segment increase of 25% to $1.73B, United States segment increase of 35% to $1.5B. Net Income reflects Technologies & Equipment segment income increase of 72% to $541M.
Equity composition
Common Stock $.01 Par, 3/11, 200M auth., 162,800,000 issd.,less 21,900,000M shs. in Treas. @ $750.6M. Insiders control 0.29%. PO:11/93, 3.3M shares @ $39 by Goldman Sachs. FY'99 Summ.Qs reflect reclassification. 2/02, 3-for-2 stock split. 7/06, 2-for-1 stock split.
Industry: | Medical Equipment, Supplies & Distribution (NEC) |
Suite 60W
221 West Philadelphia Street
YORK
PENNSYLVANIA 28277-3607
US
Income Statement
- Annual
- Quarterly
News

How to Trade The Triple Top
Welcome to Part 5 of our 7-part Power Patterns series. In this series, we'll be equipping you with the skills to trade some of the most indicative price patterns which occur on any timeframe in every market.
14:13, 27 September 2023
Q4 lookahead: US indices starting to show signs of trouble?
US indices start to draw attention as traders focus on the outlook for Q4.
07:20, 27 September 2023
USD/JPY Climbs Towards Key Highs
USDJPY’s powerful long-term uptrend has been reignited after last week’s sharply contrasting policy statements from the Federal Reserve and Bank of Japan.
11:32, 26 September 2023
EUR/USD tests key support
EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.
14:32, 21 September 2023
BoE leaves rates unchanged, GBP drops further as investors look for more clarity
The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August
11:45, 21 September 2023
GBP softer after CPI surprise, JPY focused on any further hints from Ueda
GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.
12:42, 20 September 2023
How to Trade The Break & Retest
In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.
11:59, 20 September 2023People also watch
Still looking for a broker you can trust?
Join the 555.000+ traders worldwide that chose to trade with Capital.com